Health Care • Biotechnology: Pharmaceutical Preparations
$64.46 ▲ +1.44
(+2.29%)
MKT CAP: $5.38B • VOL: 1.52M
52W L $59 52W H $91
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$54
MEDIAN
$72
MEAN
$73
HIGH
$88
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE PTCT TAPE
PTCT // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $78.00 | $74.13 | 2025-02-14 | $58.66 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $81.22 | $76.06 | 2025-02-06 | $60.59 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $73.48 | $70.91 | 2025-01-29 | $61.88 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $65.75 | — | 2025-01-17 | $63.17 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $56.72 | $61.24 | 2025-01-09 | $57.37 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $76.71 | $67.04 | 2024-12-18 | $56.08 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $62.53 | $65.10 | 2024-12-04 | $59.95 | -4.3% | 48% | C |